Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus viatorr stent-grafts (VSG)

Purpose: To compare retrospectively angiographical and clinical results in patients undergoing transjugular intrahepatic portosystemic stent-shunt (TIPS) using BMS or VSG. Materials and methods: From February 2001 to January 2010, 245 patients underwent TIPS. From those, 174 patients matched the inc...

Full description

Saved in:
Bibliographic Details
Main Authors: Sommer, Christof-Matthias (Author) , Gockner, Theresa (Author) , Stampfl, Ulrike (Author) , Bellemann, Nadine (Author) , Sauer, Peter (Author) , Ganten, Tom M. (Author) , Weitz, Jürgen (Author) , Kauczor, Hans-Ulrich (Author) , Radeleff, Boris (Author)
Format: Article (Journal)
Language:English
Published: 2012
In: European journal of radiology
Year: 2011, Volume: 81, Issue: 9, Pages: 2273-2280
ISSN:1872-7727
DOI:10.1016/j.ejrad.2011.06.037
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.ejrad.2011.06.037
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0720048X1100578X
Get full text
Author Notes:Christof M. Sommer, Theresa L. Gockner, Ulrike Stampfl, Nadine Bellemann, Peter Sauer, Tom Ganten, Juergen Weitz, Hans U. Kauczor, Boris A. Radeleff
Description
Summary:Purpose: To compare retrospectively angiographical and clinical results in patients undergoing transjugular intrahepatic portosystemic stent-shunt (TIPS) using BMS or VSG. Materials and methods: From February 2001 to January 2010, 245 patients underwent TIPS. From those, 174 patients matched the inclusion criteria with elective procedures and institutional follow-up. Group (I) consisted of 116 patients (mean age, 57.0±11.1 years) with BMS. Group (II) consisted of 58 patients with VSG (mean age, 53.5±16.1 years). Angiographic and clinical controls were scheduled at 3, 6 and 12 months, followed by clinical controls every 6 months. Primary study goals included hemodynamic success, shunt patency as well as time to and number of revisions. Secondary study goals included clinical success. Results: Hemodynamic success was 92.2% in I and 91.4% in II (n.s.). Primary patency was significantly higher in II compared to I (53.8% after 440.4±474.5 days versus 45.8% after 340.1±413.8 days; p<0.05). The first TIPS revision was performed significantly later in II compared to I (288.3±334.7 days versus 180.1±307.0 days; p<0.05). In the first angiographic control, a portosystemic pressure gradient ≥15mmHg was present in 73.9% in I and in 39.4% in II (p<0.05). Clinical success was 73.7-86.2% after 466.3±670.1 days in I and 85.7-90.5% after 617.5±642.7 days in II (n.s.). Hepatic encephalopathy was 37.5% in I and 36.5% in II (n.s.). Conclusion: VSG increased primary shunt patency as well as decreased time to and number of TIPS revisions. There was a trend of higher clinical success in VSG without increased hepatic encephalopathy.
Item Description:Available online 23 July 2011
Gesehen am 26.07.2018
Physical Description:Online Resource
ISSN:1872-7727
DOI:10.1016/j.ejrad.2011.06.037